Canbex Therapeutics receives £1.75 million towards MS rx

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Canbex Therapeutics receives £1.75 million towards MS rx

Postby MSUK » Thu Mar 24, 2011 3:30 am

Image

Canbex Therapeutics Ltd. (Canbex) announced today that it has received a Translation Award of up to 1.75 million ($2.8 million) from the Wellcome Trust to support development of a drug for the treatment of the debilitating muscle spasms associated with multiple sclerosis and potentially other disorders.

The award will facilitate further preclinical development of Canbex's VSN series of compounds and the progression into clinical trials. It is anticipated that a Phase I trial of lead compound VSN16R could begin in December 2012.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1743
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2184
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: DougL


Contact us | Terms of Service